Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-22

Clinical Trial Update: Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of abobotulinumtoxinA for platysmal bands has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AbobotulinumtoxinA (abobotulinumtoxinA)

Snippet

Sponsor: Galderma R&D | Conditions: Platysmal Bands | Phase 2 | Status: COMPLETED | Results posted: 2021-01-22